Skip to main content

Intraarterial Chemotherapy for Brain Tumors: A Summary of the Ottawa Experience

  • Chapter
Book cover Brain Oncology Biology, diagnosis and therapy

Part of the book series: Developments in Oncology ((DION,volume 52))

  • 49 Accesses

Abstract

Intraarterial administration of chemotherapy results in augmentation of both local peak plasma concentration of the drug and local area under the concentration - times - time curve (AUC) during the drug infusion (1–4). It can be particularly advantageous to administer drugs with a rapid total body clearance intraarterially since if clearance is rapid, the usual AUC will be relatively small, and the local increase in AUC resulting from intraarterial administration will be proportionally quite large (3, 4). For some drugs, intraarterial administration would be expected to result in increased therapeutic efficacy, while for other drugs, there would be relatively little advantage (1–4). Augmentation of local tissue concentrations by intraarterial administration has been documented for some drugs (5–9), but not for others (10).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fenstermacher (J.D.), Cowles (A.K.).Theoretic limitations of intracarotid infusions in brain tumor chemothe-1980.

    Google Scholar 

  2. Chen (H-SG), Gross (J.F.). Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31–40 (1980).

    PubMed  CAS  Google Scholar 

  3. Collins (J.) Pharmacologic rationale for regional drug delivery. J. Clin Oncol 2: 498–504 (1984).

    PubMed  CAS  Google Scholar 

  4. Ensminger (W.), Gyves (J.). Clinical pharmacology of hepatic arterial chemotherapy. Semin. Oncol. 10: 176–182 (1983).

    PubMed  CAS  Google Scholar 

  5. Stewart (D.J.), Leavens (M.), Maor (M.), Feun (L.), Luna (M.), Bonura (J.), Caprioli (R.), Loo (T.L.), Benjamin (R.S.): Human central nervous system distribution of Cis-Diaminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Research 42: 2474–2479 (1982).

    PubMed  CAS  Google Scholar 

  6. Stewart (D.J), Mikhael (N.), Nanji (A.), Kacew (S.), Maroun (J.), HIRTE W: Human tissue cisplatin (CP) pharmacology: clinical implications. Proc Amer Assoc Cancer Res 26: 154 (1985).

    Google Scholar 

  7. Levin (V.A.), Kabra (P.M.), Freeman-Dove (M.A.). Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. Neurosurgery 48: 587–593 (1978).

    Article  CAS  Google Scholar 

  8. Carlson (J.A. Jr.), Litterst (C.L.), Greenberg (R.A.), Day (T.G. Jr.), Masterson (B.J.). Platinum tissue concentrations following intra-arterial and intravenous cis-diamine-dichloroplatinum II in New Zealand white rabbits. Am J Obstet Gynecol 148: 313–317 (1984).

    PubMed  CAS  Google Scholar 

  9. Stewart (D.J.), Novel modes of chemotherapy administration. in: Rosenblum (M.L.), Wilson (C.B.) (eds). Progress in experimental brain tumor research (S. Kargel Med & Scientific Publishers. Basel/Switzerland, 1984) 28: 32–50.

    Google Scholar 

  10. Madajewicz (S.), Spaulding (M.), Bhimani (S.), Avellanosa (A.), De Los Santos (R.), Perry (A.), Zeigler (P.), Kirshner (J.). Phase I-II Diaziquone chemotherapy in brain tumors. Cancer Treat Rep 68: 913–914 (1984).

    PubMed  CAS  Google Scholar 

  11. Bonstelle (C.T.), Kori (S.H.), Rekate (H.). Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption. AJNR 4: 810–812 (1983).

    PubMed  CAS  Google Scholar 

  12. Feun (L.G.), Lee (Y.-Y.), Yung (W.K.A.), Charnsangavej (C.), Savaraj (N.), Tang (R.A.), Wallace (S.). Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Cancer Drug Delivery 3: 147–156 (1986).

    Article  PubMed  CAS  Google Scholar 

  13. Yamashita (J.), Handa (H.), Tokuriki (Y.), Ha (Y.S.), Otsuka (S.-I), Suda (K.), Taki (W.). Intra-arterial ACNU therapy for malignant brain tumors: experimental studies and preliminary clinical results. J. Neurosurg 59: 424–430 (1983).

    Article  PubMed  CAS  Google Scholar 

  14. Bremer (A.M.), Kleriga (E.), Nguyen (E.), Balsys (R.), Northup (H.M.), Gonzalez (N.), Duarte (P.), Miller (R.I.). Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors. J. Neuro-Oncol 2: 129–132 (1984).

    CAS  Google Scholar 

  15. Calvo (F.A.), Pastor (M.A.), Dy (C.), Algeria (E.), Aparicio (L.M.A.), Gil (A.), Harguindey (S.), Zubieta (J.L.), Lage (M.M.). Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma: preliminary results. Am J. Clin Oncol (CLT) 8: 200–209 (1985).

    Article  CAS  Google Scholar 

  16. Stewart (D.J.), Grahovac (Z.), Gupta (S.) Goumnerova (L.), Richard (M.), Hugenholtz (H.), Maroun (J.): Phase I study of intracarotid PCNU. J Neuro-Oncol 4: 114 (1986).

    Google Scholar 

  17. Feun (L.G.). Intra-arterial chemotherapy for primary and metastatic brain cancer: Cancer Bulletin 36: 57–61 (1984).

    Google Scholar 

  18. Greenberg (H.S.), Ensminger (W.), Layton (P.), Gebarski (S.), Meyer (M.B.), Bender (J.), Grillo-Lopez (A.). A phase I-II evaluation of intra-arterial diaziquone (AZQ) for malignant tumors of the central nervous system. Proc Am Soc Clin Oncol 3: 256 (1984).

    Google Scholar 

  19. West (C.R.), Avellanosa (A.M.), Barua (N.R.), Patel (A.R.). Phase II study of intra-arterial (IA) BCNU plus VM-26 for malignant gliomas and for metastatic brain tumors. Proc Am Soc Clin Oncol 2: 234 (1983).

    Google Scholar 

  20. Mughal (T.), Glode (L.M.), Braun (T.J.), Geyer (M.), Kindt (G.). Phase I study of intra-arterial bis-chloroethyl nitrosourea and 2′-deoxy-5-fluoridine in malignant astrocytomas. Proc Am Assoc Cancer Res 25: 198 (1984).

    Google Scholar 

  21. Stewart (D.J.), Grahovac (Z.), Benoit (B.), Addison (D.), Richard (M.T.), Dennery (J.), Hugenholtz (H.), Russell (N.), Peterson (E.), Maroun (J.A.), Vandenberg (T.), Hopkins (H.S.). Intracarotid chemotherapy with a combination of 1, 3-Bis (2-chloroethyl)-1-nitrosourea (BCNU), cis-Diaminedichloroplatinum (Cisplatin) and 4’-O-Demethyl-l-0 (4, 6-0-2-thenylidene-β-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurg 15: 828–833 (1984).

    Article  CAS  Google Scholar 

  22. Stewart (D.J.), Wallace (S.), Feun (L.), Leavens (M.), Young (S.E.), Handel (S.), Mavligit (G.), Benjamin (R.S.). Intracarotid artery infusion of Cis-Diaminedichloroplatinum: phase I study in patients with recurrent malignant intracerebral tumors. Cancer Res 42: 2059–2062 (1982).

    PubMed  CAS  Google Scholar 

  23. Feun (L.G.), Wallace (S.), Stewart (D.J.), Chuang (V.P.), Yung (W-KA), Leavens (M.E.), Burgess (M.A.), Savaraj (N.), Benjamin (R.S.), Young (S.E.), Tang (R.A.), Handel (S.), Mavligit (G.), Fields (W.S.). Intracarotid infusion of Cis-Diaminedichloroplatinum in the treatment of recurrent malignant tumors. Cancer 54: 794–799 (1984).

    Article  PubMed  CAS  Google Scholar 

  24. Madajewicz (S.), West (C.R.), Park (H.C.), Avellanosa (A.M.), Caracandas (J.E.), Takita (H.), Vincent (R.G.), Jennings (E.). Phase II study of intra-arterial 4’-0-demethyl-1-0-(4,6-0-2-thynylidene-β-D-glycopyranosyl) epipodophyllotoxin (VM-26) therapy of metastic bronchogenic adenocarcinoma to the brain. Proc Am Soc Clin Oncol 22: 502 (1981).

    Google Scholar 

  25. Madajewicz (S.), West (C.R.), Park (H.C.), Ghoorah (J.), Avellanosa (A.M.), Takita (H.), Karakousis (C.), Vincent (R.), Caracandas (J.), Jennings (E.). Phase II study - intraarterial BCNU therapy for metastatic brain tumors. Cancer 47: 653–657 (1981).

    Article  PubMed  CAS  Google Scholar 

  26. Drewinko (B.), Gottleib (J.). Action of cis-dichlorodiamineplatinum (II) (NSC-119875) at the cellular level. Cancer Chemother Rep 59: 665–673 (1975).

    PubMed  CAS  Google Scholar 

  27. Issell (B.). The podophyllotoxin-derivatives VP-16-213 and VM-26. Cancer Chemother Pharmacol 7: 73–80 (1982).

    PubMed  CAS  Google Scholar 

  28. Dewayne (R.), Peck (C.), Hilliard (S.), Karas (J.). Response of L1210 leukemia to treatment with 1, 3-bis (2-chloroethyl)-1-nitrosourea plus 4’-demethylepipodophyllotoxin-9-(4, 6-0-2-thenylidene-β-D-glucopyranoside). Cancer Res 41: 3891–3895 (1981).

    Google Scholar 

  29. Stewart (D.J.), Grahovac (Z.), Hugenholtz (H.), Benoit (B.), Richard (M.). Russell (N.), Maroun (J.), Dennery (J.), Peterson (E.), Nabwangu (J.). Intraarterial plus systemic chemotherapy in the treatment of intracerebral tumors. J. Neuro-Oncol 4: 114 (1986).

    Google Scholar 

  30. Djerassi (I.), Sun Kim (J.), Shulman (K.). High-dose methotrexate-citrovorum factor rescue in the management of brain tumors. Cancer Treat Rep 61: 691–694 (1977).

    PubMed  CAS  Google Scholar 

  31. Rosenstock (J.G.), Evans (E.), Schut (L.). Response to vincristine of recurrent brain tumors in children. J. Neurosurg 45: 135–140 (1976).

    Article  PubMed  CAS  Google Scholar 

  32. Takeuchi (K.). A clinical trial of intravenous bleomycin in the treatment of brain tumors. Int J. Clin Pharmacol 12: 419–426 (1975).

    CAS  Google Scholar 

  33. Kumar (A.), Renaudin (J.), Wilson (C.), Boldrey (E.), Enot (K.), Levin (V.). Procarbazine hydrochloride in the treatment of brain tumors. J. Neurosurg 40: 365–371 (1974).

    Article  Google Scholar 

  34. Sklansky (B.), Mann-Kaplan (R.), Reynolds (A.), Rosenblum (M.), Walker (M.). 4’-Demethyl-epipodophyllotoxin-β-D-thenylidene-glucoside (PTG) in treatment of malignant intracranial neoplasms. Cancer 33: 460–467 (1974).

    Article  PubMed  CAS  Google Scholar 

  35. Barraneo (S.), Kue (J.), Romsdahl (M.), Humphrey (R.). Bleomycin as a possible synchronizing agent for human tumor cells in vivo. Cancer Res 33: 882–887 (1973).

    Google Scholar 

  36. Chello (P.), Sirotvak (F.), Dorick (D.), Moccio (D.). Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia. Cancer Treat Rep 63: 1889–1894 (1974).

    Google Scholar 

  37. Stewart (D.J.), Richard (M.T.), Hugenholtz (H.), Dennery (J.), Nundy (D.), Prior (J.), Montpetit (V.), Hopkins (H.S.). Penetration of teniposide (VM-26) into human intracerebral tumors : preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with Amphotericin-B or oral glycerol. J. Neuro-Oncol 2: 315–324 (1984).

    CAS  Google Scholar 

  38. Lehane (D.E.), Bryan (R.N.), Horowitz (B.), De Santos (L.), Ehni (G.), Zubler (M.A.), Moiel (R.), Rudolph (L.), Aldama-Leubbert (A.), Mahoney (D.), Harper (R.). Intraarterial cisplatinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug Delivery 1: 69–77 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. Bergerat (J.P.), Drewinko (B.), Corry (P.), Barlogie (B.), Ho (D.H.). Synergistic lethal effect of cis-dichlorodiamineplatinum and 1-β-D-arabinofuranosylcytosine. Cancer Res 41: 25–30 (1981).

    PubMed  CAS  Google Scholar 

  40. Kyriazis (A.P.), Kyriazis (A.A.), Martelo (A.J.). Response to single agent and combination chemotherapy of a human pancreatic carcinoma grown in nude mice. Proc Am Assoc Cancer Res 22: 211 (1981).

    Google Scholar 

  41. Schabel (F.M.) Jr, Laster (W.R.) Jr, Trader (M.W.), Corbett (T.H.), Griswold (D.P.) Jr. Combination chemotherapy with nitrosoureas plus other anticancer drugs against animal tumors. in : Prestayko (A.W.), Crooke (A.T.), Baker (L.H.), Carter (S.K.), Schein (P.S.), (eds). Nitrosoureas: Current Status and New Developments. (Academic Press, New York, New York, 1981): 9–26.

    Google Scholar 

  42. Opfell (R.), Muggia (F.). The role of VM-26 (teniposide: NSC 122819) in chemotherapy of cancer. Chemoterapia 1: 98–101 (1982).

    Google Scholar 

  43. Boghdan (U.). Chemosensitivity of malignant brain tumors: preliminary results. J. Neuro-Oncol 1: 149–166 (1983).

    Google Scholar 

  44. Stewart (D.J.), O’Bryan (M.), Al-Sarraf (M.), Costanzi (J.J.), Oishi (N.). Phase II study of cisplatin in recurrent astrocytomas in adults. J. Neuro-Oncol 1: 145–147 (1983).

    CAS  Google Scholar 

  45. Stewart (D.J.), Richard (M.), Hugenholtz (H.N.), Benoit (B.), Russel (N.), Dennery (J.), Peterson (E.), Maroun (J.A.). Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J. Neuro-Oncol 2: 29–34 (1984).

    Article  CAS  Google Scholar 

  46. Meyer (J.), Fukuuchi (Y.), Shimazu (K), Mathew (N.), Ohuchi (T.). Effect on regional cerebral blood flow of compression by a mass lesion. Europ Neurol 8: 83–91 (1972).

    Article  PubMed  CAS  Google Scholar 

  47. Villemure (J.G.), personal communication.

    Google Scholar 

  48. Stewart (D.J.), Grahovac (Z.), Richard (M.T.), Benoit (B.), Maroun (J.A.), Hugenholtz (H.), Russel (N.), Dennery (J.), Peterson (E.), Luke (B.), Ventureya (E.G.), Girard (A.), Hopkins (H.S.). Phase i study of intraarterial mitomycin-c for recurrent intracerebral tumors. in: Walker (M.), Thomas (D.) (eds) Biology of Brain Tumor (Martinus Nijhoff Publishers, Dordrecht, The Netherlands) (1986): pp. 469–474.

    Chapter  Google Scholar 

  49. Stewart (D.J.), Grahovac (Z.), Maroun (J.), Hugenholtz (H.), Benoit (B.), Richard (M.), Russel (N.), Dennery (J.), Peterson (E.), Luke (B.), Hopkins (H.). Intraarterial (IA) chemotherapy (CT) for brain tumors (BT). Proc Amer Soc Clin Oncol 4: 132 (1985).

    Google Scholar 

  50. Misra (N.C.), Jaiswal (M.), Singh (R.), Das (B.). Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in the treatment of primary and metastatic liver carcinoma. Cancer 39: 1425–1429 (1977).

    Article  PubMed  CAS  Google Scholar 

  51. Takakura (K.). Chemotherapy of metastatic brain tumors with particular reference to continuous intracranial infusion of mitomycin-C and a radiosensitizing agent BUDR. Jpn J. Cancer Clin 17: 263–268 (1971).

    CAS  Google Scholar 

  52. Stewart (D.J), Grahovac (Z.), Riding (M.), Gupta (S.), Hugenholtz (H.), Da Silva (V.), Richard (M.), Benoit (B.), Russel (N.), Maroun (J.), Verma (S.). Intracarotid (IC) PCNU: an NCI Canada study. Proc Am Soc Clin Oncol 5: 136 (1986).

    Google Scholar 

  53. Stewart (D.J.), Benjamin (R.S.), Leavens (M.), Valdivieso (M.), Burgess (M.A.), Bodey (G.P.). Phase I study of intravenous 1-(2-Chloroethyl)-3-(2, 6-Dioxo-3-Piperidyl)-l-Nitrosourea (PCNU, NSC 95466) in adults with solid tumors. Cancer Res 40: 3750–3754 (1980).

    PubMed  CAS  Google Scholar 

  54. Feun (L.G.), Stewart (D.J.), Leavens (M.E.), Burgess (M.A.), Savaraj (N.), Benjamin (R.S.), Bodey (G.P). A phase II trial of 1-(2-Chloroethyl)-3-(2, 6-Dioxo-3-Piperidyl)-1-Nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. J. Neuro-Oncol 1: 45–48 (1983).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Stewart, D.J. (1987). Intraarterial Chemotherapy for Brain Tumors: A Summary of the Ottawa Experience. In: Chatel, M., Darcel, F., Pecker, J. (eds) Brain Oncology Biology, diagnosis and therapy. Developments in Oncology, vol 52. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3347-7_72

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3347-7_72

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8003-3

  • Online ISBN: 978-94-009-3347-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics